Home » Clinical Trials » Search Clinical Trials
Therapeutic Areas: Endocrinology | Ophthalmology | Family Medicine
Clinical Trials: Diabetic Macular Edema
A listing of clinical trials currently looking for volunteers to enroll in Diabetic Macular Edema studies. Click on the closest city to find more detailed information on a research study in your area.
Arizona
Phoenix : Retina Consultants of Arizona
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
California
Beverly Hills : Retina-Vitreous Associates
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Marietta : Marietta Eye Clinic
Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium
Sacramento : Retinal Consultants Medical Group, Inc.
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Florida
Lakeland : Central Florida Retina Institute
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for DME
Winter Haven : Center for Retina and Macular Disease
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Indiana
Indianapolis : Thomas A. Cuilla, MD, PC at Midwest Eye Institute
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Iowa
Marshalltown : Wolfe Eye Clinic
Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium
Kentucky
Paducah : Paducah Retinal Center
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for DME
Maryland
Baltimore : Wilmer Eye Institute, Johns Hopkins University
A Randomized, Multi-center, Phase II Study of the Safety, Tolerability and Bioactivity of Repeated Intravitreal Injections of iCo-007 as Monotherapy or in Combination With Ranibizumab or Laser Photocoagulation in the Treatment of Diabetic Macular Edema (the iDEAL Study)
Baltimore : Elman Retina Group, P.A.
Comparative Effectiveness Study of Intravitreal Aflibercept, Bevacizumab, and Ranibizumab for DME
Baltimore : Johns Hopkins University
SAR 1118 in Human Subjects Undergoing Pars Plana Vitrectomy
Massachusetts
Boston : Ophthalmic Consultants of Boston
Safety Study of Bromfenac Ophthalmic Solution in Subjects With Diffuse Diabetic Macular Edema (DME) Refractory to Laser
New Hampshire
Portsmouth : Eyesight Ophthalmic Services, PA
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
New Jersey
Toms River : Retina Vitreous Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
North Carolina
Charlotte : Southeast Clinical Research Associates, LLC
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Pennsylvania
West Mifflin : Associates in Ophthalmology
Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium
South Dakota
Rapid City : Black Hills Regioinal Eye Institute
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Texas
Harlingen : Valley Retina Institute
Continuation of Previous Study to Gather More Data on Effect of Macugen on the Corneal Endothelium
Houston : Retina Consultants of Houston
Efficacy and Safety Trial of Intravitreal Injections Combined With PRP for the Treatment of CSME Secondary to Diabetes Mellitus (DAVE)
Houston : Retinal Consultants of Houston
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
McAllen : Valley Retina Institute
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
San Antonio : Retinal Consultants of San Antonio
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Argentina
Buenos Aires : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Rosario : Novartis Investigative site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Australia
Adelaide : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Brisbane : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
East Melbourne : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Fitzroy : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Forster : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
View More »
Hobart : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Kogarah : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
North Adelaide : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Parramatta : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
South Launceston : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Strathfield : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Sydney : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Westmead : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Belgium
Bonheiden : Novartis Investigative site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Hasselt : Novartis Investigative site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Leuven : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Canada
Calgary : Calgary Retina Consultants
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Drummondville : Clinique ChirurgiVision
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Halifax : Victoria General Hospital, Department of Ophthalmology
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
London : Ivey Eye Institute
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
London Ontario : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
View More »
Miramichi : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Mississauga : Canadian Centre for Advanced Eye Therapeutics
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Montreal : Hôpital Notre Dame (CHUM)
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Montreal : Hôpital Maisonneuve-Rosemont
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Montreal : Royal Victoria Hospital
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Ottawa : The Ottawa Hospital - General Campus
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Quebec : Institut de l'oeil des Laurentides
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Québec : Centre Oculaire de Québec
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Saskatoon : Saskatoon City Hospital / Spadina Clinic
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Sherbrooke : Dr.Michel Giunta Clinique Médicale
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
St-John's : Memorial University Health Sciences Centre / Bense Eye Centre
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
St-John's : Memorial University Health Sciences Centre / Newfoundland Drive Medical Clinic
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Toronto : Sunnybrook Health Sciences Centre
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Toronto : Toronto Western Hospital
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Toronto : St-Michael's Hospital - Dept of Ophthalmology
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Vancouver : UBC - Eye Care Center
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Victoria : Retina Consultants of Victoria
Safety, Efficacy and Cost-efficacy of Ranibizumab (Monotherapy or Combination With Laser) in the Treatment of Diabetic Macular Edema (DME)
Israel
Jerusalem : Hadassah Ein Kerem Medical Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Petah Tiqva : Rabin Medical Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Rehovot : Kaplan Medical Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Tel Aviv : Tel Aviv Sourasky Medical Center
Evaluation of the Effects of Selective Photocoagulation for the Treatment of Diabetic Macular Edema
Tel Aviv : Tel Aviv Sourasky Medical Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
View More »
Zerifin : Assaf Harofe Medical Center
PF-04523655 Dose Escalation Study, and Evaluation of PF-04523655 With/Without Ranibizumab in Diabetic Macular Edema (DME)
Japan
Osaka : Santen study sites
Efficacy and Safety of Betamethasone Microsphere in Patients With Diabetic Macular Edema (TSUBASA)
Netherlands
Tilburg : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Norway
Bodo : Novartis Investigative site
Ranibizumab "Treat and Extend" in Diabetic Macular Edma
Oslo : Novartis Investigative Site
Ranibizumab "Treat and Extend" in Diabetic Macular Edma
Trondheim : Novartis Investigative site
Ranibizumab "Treat and Extend" in Diabetic Macular Edma
Singapore
Singapore : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
United Kingdom
Bolton : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
County Durham : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Essex : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Manchester : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Norfolk : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
View More »
Sheffield : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Stoke on Trent : Novartis Investigative Site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
Surrey : Novartis Investigative site
Observe the Effectiveness and Safety of Ranibizumab in Real Life Setting
